Unitrade Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 20-06-2024
- Paid Up Capital ₹ 0.10 M
as on 20-06-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 86.88%
(FY 2022)
- Profit 61.70%
(FY 2022)
- Ebitda 113.52%
(FY 2022)
- Net Worth -63.35%
(FY 2022)
- Total Assets -61.92%
(FY 2022)
About Unitrade Remedies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prashant Jadhav and Yusuf Patel serve as directors at the Company.
- CIN/LLPIN
U85100MH2014PTC253760
- Company No.
253760
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Unitrade Remedies Private Limited offer?
Unitrade Remedies Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Herbal Piles Medicine, Ayurvedic & Herbal Health Supplement, Herbal Juice, Ayurvedic Herbal Syrups & Tonics, Ayurvedic Health Tonic, Noni Juice, Hair Oil, Herbal Hair Oil, Ayurvedic Medicine.
Who are the key members and board of directors at Unitrade Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Jadhav  | Director | 03-Mar-2014 | Current |
| Yusuf Patel | Director | 03-Mar-2014 | Current |
Financial Performance of Unitrade Remedies.
Unitrade Remedies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 86.88% increase. The company also saw a substantial improvement in profitability, with a 61.7% increase in profit. The company's net worth observed a substantial decline by a decrease of 63.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unitrade Remedies?
In 2019, Unitrade Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unitrade Remedies?
Unitrade Remedies has a workforce of 2 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unitrade Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unitrade Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
